{
    "id": 23148,
    "cites": 41,
    "cited_by": 5,
    "reference": [
        "Agrawal, Shantanu, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Combatting The Opioid Epidemic: A Review of Anti-Abuse Efforts By Federal Authorities and Private Insurers, Testimony before U.S. Senate Committee on Homeland Security and Government Affairs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Technical Report, CMS, Washington, DC September 2016. Available at https://www. hhs.gov/about/agencies/asl/testimony/2016-09/a-review-of-anti-abuse-efforts/index.html.",
        "Alpert, Abby, David Powell, and Rosalie Liccardo Pacula, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d December 2016. Available at http://www.rand.org/pubs/working_papers/WR1181.html.",
        "Arditi, Lynn, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093New law: Health-care providers must register in prescription database,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Providence Journal, 2014, May 29, 2014.",
        "Bertrand, Marianne, Esther Duflo, and Sendhil Mullainathan, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093How Much Should We Trust Differences-In-Differences Estimates,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics, 2004, 119 (1).",
        "Blum, Jonathan, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Curbing Prescription Drug Abuse in Medicare, Testimony before U.S. Senate Committee on Homeland Security and Government Affairs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Technical Report, Director, Center for Medicare Management, Washington, DC June 2013. Available at http://www.hhs.gov/asl/testify/2013/06/4483.html.",
        "Borgschulte, Mark, Adriana Corredor-Waldron, and Guillermo Marshall, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A Path Out: Prescription Drug Abuse and Suicide,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d December 2016. Available at https://sites.google.com/site/ markborgschulte/research.",
        "Brady, Joanne E., Hannah Wunsch, Charles J. DiMaggio, Barbara H. Lang, James Giglio, and Guohua Li, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription drug monitoring and dispensing of prescription opioids,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Public Health Reports, 2014, 129.",
        "Brewer, Mike, Thomas F. Crossley, and Robert Joyce, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Inference with Difference-in-Differences Revisited,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d November 2013. IZA Discussion Paper No. 7742.",
        "Cameron, A. Colin, Jonah B. Gelbach, and Douglas L. Miller, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Bootstrap-Based Improvements for Inference with Clustered Errors,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Review of Economics and Statistics, 2008, 90 (3).",
        "Case, Anne and Angus Deaton, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Proceedings of the National Academy of Sciences, 2015, 112 (49), 15078\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 15083.",
        "Chen, Li Hui, Holly Hedegaard, and Margaret Warner, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2011,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Technical Report, National Center for Health Statistics, Washington, DC September 2014. NCHS Data Brief No. 166.",
        "CMS, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Opioid Morphine Equivalent Conversion Factors,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d https://www.cms.gov/ Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/ Opioid-Morphine-EQ-Conversion-Factors-March-2015.pdf 2015. Accessed: February 2, 2016.",
        "Dart, Richard C., Hilary L. Surratt, Theodore J. Cicero, Mark W. Parrino, Geoff Severtson, Becki Bucher-Bartelson, and Jody L. Green, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Trends in Opioid Analgesic Abuse and Mortality in the United States,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d New England Journal of Medicine, 2015, 372 (3).",
        "Davis, Corey S., Matthew Pierce, and Nabarun Dasgupta, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Evolution and Convergence of State Laws Governing Controlled Substance Prescription Monitoring Programs, 1998-2011,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Journal of Public Health, August 2014, 104.",
        "Dowell, Deborah, Kun Zhang, Rita K. Noonan, and Jason M. Hockenberry, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs, 2016, 35 (10), 1876\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1883.",
        "GAO, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093State Monitoring Programs Provide Useful Tool to Reduce Diversion,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Technical Report, Government Accountability Office, Washington, DC May 2002. GAO-02-634.",
        ", \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Instances of Questionable Access to Prescription Drugs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Technical Report, Government Accountability Office, Washington, DC September 2011. GAO-11-699.",
        "Gourlay, Kristin, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Fighting Prescription Drug Abuse, One Log In At a Time,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Rhode Island Public Radio, 2013.",
        "Haegerich, Tamara M., Leonard J. Paulozzi, Brian J. Manns, and Christopher M. Jones, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093What we know, and don\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2t know, about the impact of state policy and systems-level interventions on prescription drug overdose,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Drug and Alcohol Dependence, 2014, 145, 34 \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 47.",
        "Haffajee, Rebecca L., Anupam B. Jena, and Scott G. Weiner, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Mandatory Use of Prescription Drug Monitoring Programs,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d JAMA, 2015, 313 (9), 891\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c892.",
        "Islam, M. Mofizul and Ian S McRae, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093An Inevitable Wave of Prescription Drug Monitoring Programs in the Context of Prescription Opioids: Pros, Cons and Tensions,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d BMC Pharmacology & Toxicology, 2014, 15 (46).",
        "Jena, Anupam B., Dana Goldman, Lesley Weaver, and Pinar Karaca-Mandic, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Opioid Prescribing By Multiple Providers in Medicare: Retrospective Observational Study of Insurance Claims,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d British Medical Journal, 2014, 348.",
        "Kunins, Hillary V., Thomas A. Farley, and Deborah Dowell, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Guidelines for opioid prescription: why emergency physicians need support,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Annals of Internal Medicine, 2013, 158.",
        "Levy, Benjamin, Leonard Paulozzi, Karin A. Mack, and Christopher M. Jones, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Trends in Opioid Analgesic Prescribing Rates by Specialty, U.S., 20072012,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Journal of Preventive Medicine, 2015, 49 (3), 409 \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 413.",
        "Li, Guohua, Joanne E. Brady, Barbara H. Lang, James Giglio, Hannah Wunsch, and Charles DiMaggio, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription drug monitoring and drug overdose mortality,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Injury Epidemiology, 2014, 1 (1), 1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c8.",
        "Manchikanti, Laxmaiah, Bert Fellows, Hary Ailinani, and Vidyasagar Pampati, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Pain Physician, February 2010, 13.",
        "Meara, Ellen, Jill R. Horwitz, Wilson Powell, Lynn McClelland, Weiping Zhou, A. James O\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2Malley, and Nancy E. Morden, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093State Legal Restrictions and Prescription-Opioid Use among Disabled Adults,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d New England Journal of Medicine, 2016, 375 (1), 44\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c53.",
        "Morden, Nancy E., Jeffrey C. Munson, Carrie H. Colla, Jonathan Skinner, Julie P.W. Bynum, Weiping Zhou, and Ellen Meara, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription Opioid Use Among Disabled Medicare Beneficiaries: Intesity, Trends, and Regional Variation,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Medical Care, September 2014, 52 (9).",
        "NSDUH, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093National Survey on Drug Use and Health: Summary of National Findings,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d September 2014. Available at http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/ Web/NSDUHresults2013.htm; some results from authors\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 tabulation at http://www.icpsr.umich.edu/ icpsrweb/SAMHDA/studies/35509/datasets/1/sdaxml.",
        "Pasero, Christine L. and Margo McCaffery, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Pain Ratings: The Fifth Vital Sign,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Journal of Nursing, February 1997, 97.",
        "Patrick, Stephen W., Carrie E. Fry, Timothy F. Jones, and Melinda B. Buntin, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Health Affairs, 2016, 35 (7), 1324\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1332.",
        "Paulozzi, Leonard J., Edwin M. Kilbourne, and Hema A. Desai, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription Drug Monitoring Programs and Death Rates from Drug Overdose,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Pain Medicine, May 2011, 12 (5), 747\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c54.",
        "PDMP Center of Excellence, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Mandating PDMP participation by medical providers: current status and experience in selected states,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Technical Report, Brandeis University, Waltham, MA October 2014. Available at http://www.pdmpexcellence.org/sites/all/pdfs/COE_briefing_mandates_2nd_rev.pdf.",
        "Poston, Rebecca, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093E-FORCSE 2011\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2012 Prescription Drug Monitoring Program Annual Report,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d December 2012. Available at http://www.floridahealth.gov/statistics-and-data/e-forcse/ news-reports/_documents/2011-2012pdmp-annual-report.pdf.",
        "Reifler, Liza M., Danna Droz, J. Elise Bailey, Sidney H. Schnoll, Reginald Fant, Richard C. Dart, and Becki Bucher-Bartelson, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Do Prescription Monitoring Programs Impact State Trends in Opioid Abuse/Misuse?,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Pain Medicine, 2012, 13.",
        "Unick, George Jay, Daniel Rosenblum, Sarah Mars, and Daniel Ciccarone, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Intertwined Epidemics: National Demographic Trends in Hospitalizations for Heroin- and Opioid-Related Overdoses, 1993-2009,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d PLOS One, February 2013, 8 (2).",
        "Volkow, Nora D., \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Testimony before the Senate Caucus on International Narcotics Control on America\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Addiction to Opioids: Heroin and Prescription Drug Abuse,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d 2014. Available at www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2015/ americas-addiction-to-opioids-heroin-prescription-drug-abuse.",
        "Washington State Agency Medical Directors\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 Group, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Interagency guideline on opioid dosing for chronic non-cancer pain: an educational aid to improve care and safety with opioid treatment,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d http: //www.agencymeddirectors.wa.gov/files/opioidgdline.pdf 2010. Accessed: February 5, 2016.",
        "West, Nancy A., Stevan G. Severtson, Jody L. Green, and Richard C. Dart, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Trends in Abuse and Misuse of Prescription Opioids Among Older Adults,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Drug and Alcohol Dependence, 2015, 149.",
        "White House, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Obama Administration Announces Public and Private Sector Efforts to Address Prescription Drug Abuse and Heroin Use,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d October 2015. Available at https://www.whitehouse.gov/the-press-office/2015/10/21/ fact-sheet-obama-administration-announces-public-and-private-sector. Wisconsin Prescription Drug Monitoring Program, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Training Guide for Wisconsin Practitioners and Pharmacists,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d http://dsps.wi.gov/Documents/PDMP/Practitioners_Pharmacists_Training_Guide.",
        "pdf October 2013. Accessed: February 2, 2016. Wisconsin Department of Safety and Professional Services -Pharmacy Examining Board Training Guide for Wisconsin Practitioners and Pharmacists Accessing PDMP Data Your report results are displayed similar to the following:"
    ]
}